Clinical Trials in Georgia

Showing 14661-14680 of 19,050 trials

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

NCT00634179

This is an open-label (doctors and patients know which drug will be given), single center, phase 1/2 clinical trial. The primary objective is to determine whether VR-CHOP provides benefit to patients with previously untreated indolent non-Hodgkin's lymphomas (NHL).

Lymphoma, B-CellFollicular Lymphoma

Emory University37 participantsStarted Feb 2008

Atlanta, Georgia, United States

COMPLETEDPhase 265 miles

Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

NCT00548847

The relapse of acute leukemia, MDS and blast phase CML after allogeneic transplantation affects approximately 1/3 to 1/2 of all transplant recipients and is the main cause of treatment failure. There is currently no effective standard treatment for this condition. This study will test the activity and feasibility of using a regimen to boost the immune system in order to treat AML, ALL, blast phase CML, and MDS relapse after allogeneic transplantation.

Leukemia

Emory University15 participantsStarted Jan 2007

Atlanta, Georgia, United States

TERMINATED65 miles

T and B Cell Responses in Autoimmune Diseases

NCT01947036

The study aims to establish whether defects in immune cell function are shared across multiple autoimmune diseases and whether those problems match to similar genes in the cells.

Type 1 Diabetes MellitusMultiple SclerosisArthritis, Rheumatoid+2 more

National Institute of Allergy and Infectious Diseases (NIAID)68 participantsStarted Jan 2014

New Haven, Connecticut, United States • Atlanta, Georgia, United States • Manhasset, New York, United States +3 more locations

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

T and B Cell Responses in Autoimmune Diseases

Find Trials by Condition in Georgia

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant

A Comparison of Long-acting Injectable Medications for Schizophrenia

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age

Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF

Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery

Analgesic Efficacy & Safety of Intravenous (IV) Acetaminophen Versus Placebo for the Treatment of Postop Pain

Dose Finding Study of HP802-247 in Venous Leg Ulcers

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

The T REX Pilot Study: a Study to Investigate the Use of an Alternative Anaesthetic in Infants.

Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels

UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Study In Patients With Dyslipidaemia